Turktipsan Incorporated company, which was established on 29 July 2002 with the joint investment decision of foundations operating for the benefit of the Turkish Armed Forces, for the production of parenteral solutions in Akyurt, Ankara, continues its production in its modern facility of 22.000 m2. Turktipsan, which started its pioneering activities with the GMP certificate approved by the Ministry of Health of the Republic of Turkey, has become a first in the sector with the use of ...
Our R&D center considers developing innovative and high-value domestic products as an important step to reduce dependence on imports and continues its efforts with the goal of reflecting each developed product as an added value to the Turkish and global pharmaceutical industry.
The last Board of Directors meeting of 2025 was held on December 26th.
The District Governor of Akyurt, Mr. Hamit Genç, paid a courtesy visit to the TURKTIPSAN A.Ş. facilities along with the District Gendarmerie Commander and the District Police Chief. We thank our esteemed Governor and his accompanying delegation.
A 3-person delegation from the Directorate General of Exports of the Ministry of Commerce of the Republic of Turkey visited our company, toured our production facilities, and exchanged information about the sector with our Acting General Manager and relevant personnel.
A courtesy visit was paid to Mr. Mehmet Ali KILIÇKAYA, Director General of Exports at the Ministry of Trade of the Republic of Turkey, by İ.Enver SUNGUR, Acting General Manager of TURKTIPSAN.
A training on Generic Drug Development and DMF Review was conducted for the personnel of TURKTIPSAN A.Ş. by Ms. Samiye FIÇICIOĞLU between September 15-19, 2025. We thank her for her valuable contributions.
A courtesy visit was paid to the Acting General Manager of TURKTIPSAN A.Ş. (Ret.) Col. İ. Enver SUNGUR by the General Manager of the TSK Solidarity Foundation (Ret.) Brig. Gen. Oktay AĞBUBA. During the visit, Brig. Gen. AĞBUBA conveyed his best wishes to the newly appointed Col. SUNGUR and mentioned the company's ongoing efforts.